Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
The products will be manufactured at the company's facility in Bengaluru
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The product is expected to start contributing meaningfully to the revenue from FY25
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The brand has launched 6 new range of products to provide a complete pregnancy care solution
The products will be manufactured at the company's facility in Bengaluru
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
Subscribe To Our Newsletter & Stay Updated
